On September 10, 2025, LIXTE Biotechnology Holdings, Inc. based in Boca Raton, Florida, disclosed plans to broaden its treasury holdings and potentially pursue acquisitions through an initial investment in cryptocurrencies. The company, listed on Nasdaq under ticker symbols LIXT and LIXTW, is a clinical stage pharmaceutical firm. This strategic move indicates LIXTE's intention to expand its financial portfolio in the digital asset space, signaling a proactive approach to financial management and growth opportunities.